HIV vaccine candidate induces immune response in early clinical trial: ‘An important step forward’

0 minutes, 15 seconds Read

An experimental HIV vaccine has been found to induce broadly neutralizing antibodies among a small group of volunteers in a Phase 1 study. The findings suggest that a two-dose regimen of the vaccine given eight weeks apart can elicit immune responses against the human immunodeficiency virus. 

Article Source: Latest From CNN Read More 

Similar Posts

Leave a Reply

Your email address will not be published. Required fields are marked *